Navigation path

Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

2,3,4,5 tetrahydro-2,8-dimethyl-5-[2-(6-methyl-3-pyridyl)ethyl]-1H-pyrido[4,3-b]indole dihydrochloride

EU orphan designation number: EU/3/08/597
Active ingredient: 2,3,4,5 tetrahydro-2,8-dimethyl-5-[2-(6-methyl-3-pyridyl)ethyl]-1H-pyrido[4,3-b]indole dihydrochloride
Indication: Treatment of Huntington's disease
Sponsor: IDEA Innovative Drug European Associates Limited
4th Floor, 1 Kingdom Street, Paddington, London W2 6BD, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
22/01/2009 Orphan Designation EMEA/OD/061/08 (2009)424 of 20/01/2009
01/03/2011 Change of address of sponsor EMEA/OD/061/08
17/12/2012 Change name of sponsor
25/09/2014 Change of address of sponsor
18/02/2015 Removal of orphan designation from Community Register